Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients.
Amber E JohnsonGretchen M SwabeDaniel AddisonUtibe R EssienKhadijah BreathettLaPrincess C BrewerSula MazimbaSelma F MohammedJared W MagnaniPublished in: Circulation. Cardiovascular quality and outcomes (2022)
Lower household income is associated with decreased likelihood of a sacubitril/valsartan claim and medication adherence within 6 months of HFrEF diagnosis, even after adjusting for sociodemographic and clinical factors. Future analyses are needed to identify additional social factors associated with delays in sacubitril/valsartan initiation and long-term adherence.